机构名称：
¥ 2.0
Grow vaccines into the next earnings driver as a core business • Launch COVID-19 and influenza vaccines • Expand the business to Asia and across the world • Establishment of new technologies that will be our strength (nasal, universal vaccines) Strengthen diagnostic capabilities • Provide simple diagnostic solutions (home diagnosis kits, etc.)
在疫苗研究中建立强度和扩大投资组合
主要关键词
相关文件推荐
